56808-99-2

Upstream product

• 78-81-9 isobutylamine 
• 99-33-2 3,5-dinitrobenoyl chloride 
• 99-34-3 3,5-dinitrobenzoic acid 

Downstream Products

• 10478-01-0 3,5-dinitro-benzoic acid isobutyl ester 
• 1249811-66-2 N-isobutyl-3,5-diaminobenzamide 
• 1454710-01-0 C₅₉H₈₉N₃O₁₅ 
• 1454709-97-7 C₆₁H₉₃N₃O₁₅ 
• 1454710-08-7 C₅₄H₈₄N₆O₈ 
• 1454710-04-3 C₆₄H₁₀₀N₆O₁₂ 
• 1454710-10-1 C₄₈H₇₂N₆O₆ 
• 1454710-06-5 C₅₈H₈₈N₆O₁₀ 
• 1454710-11-2 C₄₆H₆₈N₆O₆ 
• 1454710-07-6 C₅₆H₈₄N₆O₁₀ 
• 1454709-85-3 tert-butyl (3-amino-5-(octylcarbamoyl)phenyl)carbamate 
• 99864-57-0 N-Nitro-N-isobutyl-3.5-dinitro-benzamid 
• 409322-21-0 3,5-dinitro-benzoic acid-(isobutyl-nitroso-amide) 

Relevant academic research and scientific papers

Six-membered imine ring compound and one-pot synthesis method for same

The invention belongs to the field of chemical synthesis and particularly relates to a six-membered imine ring compound and a one-pot synthesis method for same. In the method, a m-phthalaldehyde derivative and a m-phenylenediamine derivative are used as r

Aromatic oligoamide macrocycles with a backbone of reduced constraint

Oligoamide macrocycles with a backbone partially constrained by hydrogen bonds have been prepared. These macrocycles, carrying multiple H-bonding side chains, underwent strong aggregation in solution and form long fibers in the solid state. In contrast to the strong and specific complexation of the guanidinium ion by analogous macrocycles with fully H-bond-constrained backbones, these macrocycles failed to recognize the same cation, indicating that reducing backbone constraint has led to a drastic change in their cavity.

Benzamide-containing pharmaceutical compositions

A group of benzamide compounds are disclosed that are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from neurodegenerative conditions associated with dopamine depletion.